Inovalon (INOV) Tops Q1 EPS by 3c, Offers FY Guidance

Inovalon (NASDAQ: INOV) reported Q1 EPS of $0.10, $0.03 better than the analyst estimate of $0.07. Revenue for the quarter came in at $145.5 million versus the consensus estimate of $143.76 million.

GUIDANCE:

Inovalon sees FY2019 EPS of $0.42-$0.48, versus the consensus of $0.42. Inovalon sees FY2019 revenue of $637-657 million, versus the consensus of $632.9 million.

For earnings history and earnings-related data on Inovalon (INOV) click here.

You May Also Be Interested In

• HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance
• Deutsche Bank cuts Novo Nordisk to Sell after earnings, shares dip
• GSX Techedu Inc. (GOTU) Misses Q2 EPS by 11c; offers guidance